Trials / Recruiting
RecruitingNCT06558188
Combined Anabolic Therapy
Combined Anabolic Therapy Study
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
In this research study the study investigators want to learn more about the effect of two different FDA-approved medication regimens in the treatment of postmenopausal osteoporosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Romosozumab | romosozumab 210 milligrams monthly |
| DRUG | Teriparatide | teriparatide 20 micrograms daily |
Timeline
- Start date
- 2025-02-03
- Primary completion
- 2027-12-30
- Completion
- 2028-04-01
- First posted
- 2024-08-16
- Last updated
- 2026-04-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06558188. Inclusion in this directory is not an endorsement.